Laura D. Crain, MD

  • 2Articles
  • 31.8KReads
  • 2021–2023Active
  • 11Collaborators
  • 11Citations

About

Laura D. Crain, MD, is affiliated with the Center for Group Psychotherapy at Massachusetts General Hospital in Boston. Her publications between 2021 and 2023 focus on clinical approaches to depression, including pharmacotherapy and ketamine-assisted psychotherapy for treatment-resistant major depressive disorder, as well as psychotherapy for functional neurological (conversion) disorder. Her work integrates themes from neurology, psychotherapy, and rare diseases. She has frequently collaborated with co-authors such as Jonah N. Cohen and Albert Yeung.

Publications

JCP
Pharmacotherapy and Ketamine Assisted Psychotherapy for Treatment-Resistant Depression
Cross Talk: Case Conferences From MGH

Pharmacotherapy and Ketamine Assisted Psychotherapy for Treatment-Resistant Depression

April 5, 2023

A 61-year-old patient with TRD and a history of self-criticism sought ketamine assisted psychotherapy. Experts from diverse therapeutic perspectives discuss this intriguing case.
, , , et al
JCP
Cross Talk: Case Conferences From MGH

Psychotherapy for Functional Neurological (Conversion) Disorder

November 2, 2021

A complex, intriguing case is described and then is discussed by experts representing a variety of perspectives: psychodynamics, family therapy, neurology, and DBT.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe